A metiléntetrahidrofolát-reduktáz (MTHFR) C677T mutáció kimutatása kvantitatív valós ideju PCR módszer alkalmazásával HELLP szindrómás betegek mintáiban

Translated title of the contribution: Detection of methylenetetrahydrofolate reductase (MTHFR) C677T mutation by quantitative real-time PCR method in patients with HELLP syndrome

B. Nagy, P. Hupuczi, Szabó Gábor, Rigó Barbara, Papp Zoltán

Research output: Contribution to journalArticle

Abstract

The frequency of methylenetetrahydrofolate reductase C677T polymorphism has not been studied in patients with HELLP syndrome. We decided to determine it in Hungarian severe preeclamptic and HELLP syndrome patients. We determined the distribution of the MTHFR C677T mutation in DNA samples of 73 healthy pregnant, 101 severe preeclamptic and 63 HELLP syndrome effected women using the quantitative real-time PCR method. We found a significantly higher number of TT genotype (25.4%) in the HELLP syndrome group as compared to the healthy (8.2%) and also in the severe preeclamptics (8.9%)(p=0.03). However, we found almost the same genotype distribution in the healthy pregnant and preeclamptic groups. The distribution of the C and T alleles showed the same phenomenon. The frequency of the mutant T allele was 45.2% in HELLP syndrome, while it was 32.2% in the healthy pregnant (p=0.03), and 30.2% (p=0.008) in the severe preeclamptic patients. We detected a higher frequency of MTHFR C677T mutation in HELLP syndrome patients, using the quantitative real-time PCR method. It can explain the premature vascular disease and venous thrombosis observed in these patients. Determination of MTHFR genotype and the measurement of homocystein levels could be a helpful information in the management of patients having preeclampsia and HELLP syndrome.

Original languageHungarian
Pages (from-to)171-175
Number of pages5
JournalMagyar Noorvosok Lapja
Volume70
Issue number3
Publication statusPublished - 2007

Fingerprint

HELLP Syndrome
Methylenetetrahydrofolate Reductase (NADPH2)
Real-Time Polymerase Chain Reaction
Mutation
Genotype
Alleles
Information Management
Pre-Eclampsia
Vascular Diseases
Venous Thrombosis
DNA

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

A metiléntetrahidrofolát-reduktáz (MTHFR) C677T mutáció kimutatása kvantitatív valós ideju PCR módszer alkalmazásával HELLP szindrómás betegek mintáiban. / Nagy, B.; Hupuczi, P.; Gábor, Szabó; Barbara, Rigó; Zoltán, Papp.

In: Magyar Noorvosok Lapja, Vol. 70, No. 3, 2007, p. 171-175.

Research output: Contribution to journalArticle

@article{997de13a0e83492085d800915cdb0fde,
title = "A metil{\'e}ntetrahidrofol{\'a}t-redukt{\'a}z (MTHFR) C677T mut{\'a}ci{\'o} kimutat{\'a}sa kvantitat{\'i}v val{\'o}s ideju PCR m{\'o}dszer alkalmaz{\'a}s{\'a}val HELLP szindr{\'o}m{\'a}s betegek mint{\'a}iban",
abstract = "The frequency of methylenetetrahydrofolate reductase C677T polymorphism has not been studied in patients with HELLP syndrome. We decided to determine it in Hungarian severe preeclamptic and HELLP syndrome patients. We determined the distribution of the MTHFR C677T mutation in DNA samples of 73 healthy pregnant, 101 severe preeclamptic and 63 HELLP syndrome effected women using the quantitative real-time PCR method. We found a significantly higher number of TT genotype (25.4{\%}) in the HELLP syndrome group as compared to the healthy (8.2{\%}) and also in the severe preeclamptics (8.9{\%})(p=0.03). However, we found almost the same genotype distribution in the healthy pregnant and preeclamptic groups. The distribution of the C and T alleles showed the same phenomenon. The frequency of the mutant T allele was 45.2{\%} in HELLP syndrome, while it was 32.2{\%} in the healthy pregnant (p=0.03), and 30.2{\%} (p=0.008) in the severe preeclamptic patients. We detected a higher frequency of MTHFR C677T mutation in HELLP syndrome patients, using the quantitative real-time PCR method. It can explain the premature vascular disease and venous thrombosis observed in these patients. Determination of MTHFR genotype and the measurement of homocystein levels could be a helpful information in the management of patients having preeclampsia and HELLP syndrome.",
keywords = "Allele frequency, HELLP syndrome, Methylenetetrahydrofolate reductase, Mutation, Preeclampsia",
author = "B. Nagy and P. Hupuczi and Szab{\'o} G{\'a}bor and Rig{\'o} Barbara and Papp Zolt{\'a}n",
year = "2007",
language = "Hungarian",
volume = "70",
pages = "171--175",
journal = "Magyar Noorvosok Lapja",
issn = "0025-021X",
publisher = "Magyar Noovos Tarsasag",
number = "3",

}

TY - JOUR

T1 - A metiléntetrahidrofolát-reduktáz (MTHFR) C677T mutáció kimutatása kvantitatív valós ideju PCR módszer alkalmazásával HELLP szindrómás betegek mintáiban

AU - Nagy, B.

AU - Hupuczi, P.

AU - Gábor, Szabó

AU - Barbara, Rigó

AU - Zoltán, Papp

PY - 2007

Y1 - 2007

N2 - The frequency of methylenetetrahydrofolate reductase C677T polymorphism has not been studied in patients with HELLP syndrome. We decided to determine it in Hungarian severe preeclamptic and HELLP syndrome patients. We determined the distribution of the MTHFR C677T mutation in DNA samples of 73 healthy pregnant, 101 severe preeclamptic and 63 HELLP syndrome effected women using the quantitative real-time PCR method. We found a significantly higher number of TT genotype (25.4%) in the HELLP syndrome group as compared to the healthy (8.2%) and also in the severe preeclamptics (8.9%)(p=0.03). However, we found almost the same genotype distribution in the healthy pregnant and preeclamptic groups. The distribution of the C and T alleles showed the same phenomenon. The frequency of the mutant T allele was 45.2% in HELLP syndrome, while it was 32.2% in the healthy pregnant (p=0.03), and 30.2% (p=0.008) in the severe preeclamptic patients. We detected a higher frequency of MTHFR C677T mutation in HELLP syndrome patients, using the quantitative real-time PCR method. It can explain the premature vascular disease and venous thrombosis observed in these patients. Determination of MTHFR genotype and the measurement of homocystein levels could be a helpful information in the management of patients having preeclampsia and HELLP syndrome.

AB - The frequency of methylenetetrahydrofolate reductase C677T polymorphism has not been studied in patients with HELLP syndrome. We decided to determine it in Hungarian severe preeclamptic and HELLP syndrome patients. We determined the distribution of the MTHFR C677T mutation in DNA samples of 73 healthy pregnant, 101 severe preeclamptic and 63 HELLP syndrome effected women using the quantitative real-time PCR method. We found a significantly higher number of TT genotype (25.4%) in the HELLP syndrome group as compared to the healthy (8.2%) and also in the severe preeclamptics (8.9%)(p=0.03). However, we found almost the same genotype distribution in the healthy pregnant and preeclamptic groups. The distribution of the C and T alleles showed the same phenomenon. The frequency of the mutant T allele was 45.2% in HELLP syndrome, while it was 32.2% in the healthy pregnant (p=0.03), and 30.2% (p=0.008) in the severe preeclamptic patients. We detected a higher frequency of MTHFR C677T mutation in HELLP syndrome patients, using the quantitative real-time PCR method. It can explain the premature vascular disease and venous thrombosis observed in these patients. Determination of MTHFR genotype and the measurement of homocystein levels could be a helpful information in the management of patients having preeclampsia and HELLP syndrome.

KW - Allele frequency

KW - HELLP syndrome

KW - Methylenetetrahydrofolate reductase

KW - Mutation

KW - Preeclampsia

UR - http://www.scopus.com/inward/record.url?scp=34249983178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249983178&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:34249983178

VL - 70

SP - 171

EP - 175

JO - Magyar Noorvosok Lapja

JF - Magyar Noorvosok Lapja

SN - 0025-021X

IS - 3

ER -